Moderator: Hitesh P. Mehta, MD, PhD
302. The efficacy of ketamine for improvement of postoperative pain control in adolescent patients undergoing spinal fusion surgery for idiopathic scoliosis
Noah M. Walters, BS1; Ryan M. Ricciardelli, BS, MBA2; Maxwill D. Pomerantz, MD2; Benjamin Metcalfe, DO3; Melissa A. Ehlers, MD3; Paul J. Feustel, PhD2; Allen L. Carl, MD3
1Albany, NY, US; 2Albany Medical College, Albany, NY, US; 3University of Michigan, Ann Arbor, MI, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
303. Intravenous ketorolac substantially reduces opioid use following lumbar spinal fusion: early results of a randomized, double-blinded, placebo controlled trial
Sravisht Iyer, MD1; Evangelia M. Zgonis, BS2; Michael E. Steinhaus, MD2; Jeffrey J. Varghese, MD3; Dan Stein, BS24; Jingyan Yang, PhD2; Todd J. Albert, MD2; Frank J. Schwab, MD2; Darren R. Lebl, MD2; Han Jo Kim, MD2; Matthew E. Cunningham, MD, PhD2; James C. Farmer, MD2; Federico P. Girardi, MD2; Russel C. Huang, MD2; Sheeraz A. Qureshi, MD, MBA4; Bernard A. Rawlins, MD2; James D. Beckman, MD2; Harvinder S. Sandhu, MD2 1Rush University Medical Center, Chicago, IL, US; 2Hospital for Special Surgery, New York, NY, US; 3St. Joseph's Regional Medical Center, Paterson, NJ, US; 4New York, NY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
304. Disturbed sleep is associated with worse health outcomes after spine surgery
Majd Marrache, MD1; Andrew B. Harris, BS2; Micheal Raad, MD1; Amit Jain, MD3; Varun Puvanesarajah, MD4; David B. Cohen, MD, MPH5; Khaled M. Kebaish, MD5; Brian J. Neuman, MD1; Lee H. Riley III, MD6; Richard L. Skolasky, ScD5
1Baltimore, MD, US; 2Johns Hopkins Hospital, Baltimore, MD, US; 3Dept of Orthopaedic Surgery, Baltimore, MD, US; 4Johns Hopkins Medicine, Baltimore, MD, US; 5Johns Hopkins University, Baltimore, MD, US; 6Johns Hopkins Outpatient Ctr/Dept Ortho Surgery, Baltimore, MD, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
305. Differences between postoperative narcotic prescriptions in outpatient lumbar spine surgery between the United States and France
Houssam Bouloussa, MD, MS1; Soufiane Ghailane, MD2; Mohammad Alsofyani, MD3; Kamran Majid, MD4; Calvin C. Kuo, MD4; Ruwan Ratnayake, MD5; Jean-Marc Vital, MD6; Olivier Gille, MD, PhD7; Ravi S. Bains, MD4
1Kaiser Oakland Medical Center, Oakland, CA, US; 2CHU Bordeaux Spine Unit 1 - Service Pr VITAL , Bordeaux , France; 3CHU de Bordeaux, Bordeaux, aquitaine, France; 4Kaiser Permanente, Oakland, CA, US; 5UC Davis Orthopaedics, Sacramento, CA, US; 6Hôpital Pellegrin Tripode, Bordeaux, France; 7Groupe Hospitalier Pellegrin, Bordeaux, France
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion
306. Opioid-limiting legislation effectively decreases 30-day opioid utilization following anterior cervical decompression and fusion
Daniel Reid, MD, MPH1; Shyam A. Patel, MD2; Kalpit N. Shah, BS; Benjamin H. Shapiro, MS4; Jack H. Ruddell, BA4; Alan H. Daniels, MD5
1Cranston, RI, US; 2LifeSpan/Rhode Island Hospital, Providence, RI, US; 3Woonsocket, RI, US; 4Brown University Department of Orthopaedic Surgery, Providence, RI, US; 5Warren Alpert Medical School of BU/RI Hospital, Providence, RI, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
307. Zero PCA is an achievable target for postoperative rapid recovery management of AIS patients
Vishal Sarwahi, MD1; Jesse M. Galina, BS2; Aaron M. Atlas, BS3; Sayyida S. Hasan, BS3; Melanie Gambassi, NP4; Yungtai Lo, PhD5; Terry D. Amaral, MD4
1North Shore LIJ Health System, New Hyde Park, NY, US; 2New Hyde Path, US; 3Cohen Children's Medical Center, New Hyde Park, NY, US; 4Northwell Health, Lake Success, NY, US; 5Albert Einstein College of Medicine, Bronox, NY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
308. Surgical site infection after lumbar fusion surgery: risk factors and the preventive new technology
Xie En, MD
Hong Hui Hospital, Xi’an Jiaotong University College of Medicine, Xi′an, Shan Xi, China
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
309. Patient reported allergies: a marker of preoperative pain and disability in elective spine surgery
Keith W. Lyons, MD; Tracy Borsinger, MD1; Adam M. Pearson, MD, MS2; William Abdu, MD3
1Dartmouth-Hitchcock Orthopaedic Surgery, Lebanon, NH, US; 2Dartmouth Hitchcock Medical Center, Lebanon, NH, US; 3Hitchcock Clinic, Lebanon, NH, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
310. Compared to patients’ preoperative expectations, surgeons’ preoperative expectations more often correspond to patient-reported fulfillment of expectations two years after lumbar surgery
Carol A. Mancuso, MD; Roland Duculan, MD; Frank P. Cammisa, MD; Andrew A. Sama, MD; Alexander P. Hughes, MD; Darren R. Lebl, MD; Federico P. Girardi, MD
Hospital for Special Surgery, New York, NY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
311. Assessment of the effect of implementation of enhanced recovery after surgery program in spinal surgical procedures: a retrospective study
Alexandre Rasouli, MD
Rasouli Spine, Los Angeles, CA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion